Stratus Medical Named One of the Top 300 Private Companies in the Houston metro area by The Houston Business Journal™

MAGNOLIA, Texas – June 30, 2025 – Stratus® Medical is proud to announce it has been named one of the Top 300 Private Companies by the Houston Business Journal for 2025. This recognition highlights the company’s rapid growth and strong performance, with a 212% increase over the past three years.

Stratus Medical’s CEO, Bret Boudousquie, attributes the company’s growth to increasing physician adoption of the NIMBUS® RF Multitined Expandable Electrode. “NIMBUS is transforming pain management by delivering consistent, durable relief, faster procedure times, and lower costs,” said Boudousquie. “We’re honored to be recognized alongside other top-performing private companies in Houston, and we share this achievement with our customers, patients, and the dedicated Stratus team driving our mission forward.”

 

About the Houston Business Journal Top 300
The Houston Business Journal’s annual Top 300 Private Companies list honors the region’s largest privately held businesses based on revenue. Companies recognized represent the diversity and economic strength of the Greater Houston area and must meet strict criteria, including being headquartered in Houston, privately owned, and demonstrating significant business growth.

About Stratus Medical
Stratus Medical is a medical device company focused on reducing chronic pain and improving patients’ quality of life through innovation in radiofrequency (RF) technology. Its flagship product, the NIMBUS® RF Multitined Expandable Electrode, is designed to deliver large-volume lesions for long-lasting pain relief in a simple, efficient, and cost-effective manner. Stratus Medical is headquartered in Magnolia, Texas.

Media Contact
Cody Jorgensen
Marketing Communications
Stratus Medical
346-703-0642
cody@stratusmedical.com
https://stratusmedical.com

SOURCE Stratus Medical

CS1Vilims BD, Block JE. Effective management of recurrent trauma-induced neck pain with radiofrequency neurotomy using the Nimbus electrode. ASIPP. 2024;8(3):65-70.

View Full Article

Background:

Radiofrequency neurotomy (RFN) can be an effective treatment for patients with chronic neck pain and cervicogenic headaches resistant to conservative care. However, the degree and duration of pain relief after RFN is dependent upon the thoroughness of target nerve coagulation.

Case Report:

This is a case of a 37-year-old patient with debilitating neck pain and headaches following a motor vehicle accident. Successful local anesthetic block of the third occipital nerve (TON) confirmed pain of C2-C3 facet joint origin. An initial RFN treatment of the TON, using standard 18G electrodes in bipolar mode, resulted in complete symptom amelioration for 8 months. Repeat RFN, using the same electrode configuration, was unsuccessful in alleviating the severe neck pain and headaches, and produced no demonstrable sensory loss in the distribution of the TON. RFN was then performed using the NIMBUS® electrosurgical RF multitined expandable electrode, which provides a larger zone of coagulation in volume than standard RFN electrodes even when used in bipolar configuration.

Conclusion:

The NIMBUS procedure resulted in successful coagulation of the TON with sensory loss in the TON distribution and reinstatement of palliative relief.

.elementor-element-6a4dca25 .elementor-heading-title { color: #2A90C3 !important; font-weight: 400 !important; text-align: center !important; font-size: 31px !important; } .elementor-element-7f491b95 { text-align: center !important; } .elementor-element-7f491b95 .elementor-icon-list-text, .elementor-element-7f491b95 time { color: #54595F !important; } .elementor-element-7f491b95 a { color: #54595F !important; } .elementor-element-35001cdd > .e-con-inner { padding-left: 8% !important; padding-right: 8% !important; }